Search results
Results from the WOW.Com Content Network
The National Pharmaceutical Product Index or NAPPI is a comprehensive database of pharmaceutical codes for medical products classification used in South Africa.Each product has a unique NAPPI code which enables electronic data interchange throughout the health care delivery chain.
As of the Substance Act of 1965, The Medicines Control Council (MCC) and Directorate of Radiation Control (DRC) was formed. As of 2018, the South African Health Products Regulatory Authority (SAHPRA) was created to replace the MCC and DRC [4] [5]
Project Coast was a top-secret chemical and biological weapons (CBW) program instituted by the apartheid-era government of South Africa in the 1980s.Project Coast was the successor to a limited postwar CBW program, which mainly produced the lethal agents CX powder and mustard gas, as well as non-lethal tear gas for riot control purposes. [1]
(Reuters) - South African pharmacy chain Clicks Group said on Monday it would sell drug maker Unicorn Pharmaceuticals to comply with a court ruling, clearing the way for the health ministry to ...
The National Forensic DNA Database of South Africa (NFDD) is a national DNA database used in law enforcement in South Africa.The Criminal Law (Forensic Procedures) Amendment Act No. 37 of 2013 (the "DNA Act") provides for the expansion and administration of such a database in South Africa, enabling the South African Police Service (SAPS) to match forensic DNA profiles derived from samples ...
The National Institute for Communicable Diseases (NICD) is the national public health institute of South Africa, [1] providing reference to microbiology, virology, epidemiology, surveillance and public health research to support the government's response to communicable disease threats. [2] [3]
Crime in South Africa#Drug smuggling and consumption; This page is a redirect. The following categories are used to track and monitor this redirect:
South Africa's Medicines and Related Substance 1997 is a law enacted a compulsory license in order to fight HIV/AIDS epidemic. The intent of the Act was to reduce drug prices by allowing generic substitution of off-patent drugs, the parallel importation of on-patent drugs as well as price transparency.